Molecular regulators of pubertal mammary gland development

Annals of Medicine

Volumn 43, Issue 3, 2011, Pages 212-234

  McNally, Sara ^a   Martin, Finian ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Amphiregulin; ductal morphogenesis; EGFR; estrogen receptor; fibroblast growth factor; mammary gland; puberty; stem cell; terminal end bud (TEB)

Indexed keywords

ALPHA CATENIN; BETA1 INTEGRIN; BMI1 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN; ESTROGEN RECEPTOR; FIBROBLAST GROWTH FACTOR; GROWTH HORMONE; MITOGENIC AGENT; MORPHOGEN; PROGESTERONE; PROGESTERONE RECEPTOR; PROLACTIN; PROTEIN P18; PROTEIN ZO1; SCATTER FACTOR; SOMATOMEDIN; TRANSCRIPTION FACTOR GATA 3; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BREAST DEVELOPMENT; BREAST DUCT; BREAST EPITHELIUM; CELL DEATH; CELL PROLIFERATION; EPITHELIUM CELL; HUMAN; MAMMARY GLAND; NONHUMAN; PRIORITY JOURNAL; PUBERTY; STEM CELL; STROMA CELL;

ANIMALS; CYTOKINES; FEMALE; HORMONES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MAMMARY GLANDS, ANIMAL; MAMMARY GLANDS, HUMAN; MORPHOGENESIS; PUBERTY; SEXUAL MATURATION;

EID: 79953849740     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.3109/07853890.2011.554425     Document Type: Article

References (164)

1. Howard BA, Gusterson BA. Human breast development. Mammary Gland Biol Neoplasia. 2000;5:119-37. (Pubitemid 32045692)
2. Ingman WV, Robertson SA. Mammary gland development in transforming growth factor beta1 null mutant mice: systemic and epithelial effects. Biol Reprod. 2008; 79:711-7.
3. Atwood CS, Hovey RC, Glover JP, Chepko G, Ginsburg E, Robison WG, et al. Progesterone induces side-branching of the ductal epithelium in the mammary glands of peripuber-tal mice. J Endocrinol. 2000;167:39-52.
4. Sternlicht MD, Kouros-Mehr H, Lu P, Werb Z. Hormonal and local control of mammary branching morphogenesis. Differentiation. 2006;74:365-81. (Pubitemid 44215408)
5. Silberstein GB, Strickland P, Coleman S, Daniel C W. Epithelium-dependent extracellular matrix synthesis in transforming growth factor-beta 1-growth-inhibited mouse mammary gland. J Cell Biol. 1990;110:2209-19.
6. Topper YJ, Freeman CS. Multiple hormone interactions in the developmental biology of the mammary gland. Physiol Rev. 1980;60:1049-56.
7. LaMarca HL, Rosen JM. Minireview: hormones and mammary cell fate - what will I become when I grow up? Endocrinology. 2008;149:4317-21.
8. Brisken C. Hormonal control of alveolar development and its implications for breast carcinogenesis. J Mammary Gland Biol Neoplasia. 2002;7:39-48. (Pubitemid 38420780)
9. Daniel CW, Silberstein GB, Strickland P. Direct action of 17 beta-estradiol on mouse mammary ducts analyzed by sustained release implants and steroid autoradiography. Cancer Res. 1987;47:6052-7. (Pubitemid 18018753)
10. Deroo BJ, Hewitt SC, Collins JB, Grissom SF, Hamilton KJ, Korach KS. Profi le of estrogen-responsive genes in an estro-gen-specifi c mammary gland outgrowth model. Mol Reprod Dev. 2009;76:733-50.
11. Couse JF, Korach KS. Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev. 1999;20:358-417. (Pubitemid 30654784)
12. Bocchinfuso WP, Korach KS. Mammary gland development and tumorigenesis in estrogen receptor knockout mice. J Mammary Gland Biol Neoplasia. 1997;2:323-34.
13. Mallepell S, Krust A, Chambon P, Brisken C. Paracrine signaling through the epithelial estrogen receptor alpha is required for proliferation and morphogenesis in the mammary gland. Proc Natl Acad Sci USA. 2006;103: 2196-201. (Pubitemid 43271646)
14. Han SJ, DeMayo FJ, Xu J, Tsai SY, Tsai MJ, O'Malley BW. Steroid receptor coactivator (SRC)-1 and SRC-3 differentially modulate tissue-specifi c activation functions of the progesterone receptor. Mol Endocrinol. 2006;20:45-55. (Pubitemid 43011669)
15. Howlin J, McBryan J, Martin F. Pubertal mammary gland development: insights from mouse models. J Mammary Gland Biol Neoplasia. 2006;11:283-97. (Pubitemid 44869922)
16. Howlin J, McBryan J, Napoletano S, Lambe T, McArdle E, Shioda T, et al. CITED1 homozygous null mice display aberrant pubertal mammary ductal morphogenesis. Onco-gene. 2006;25:1532-42. (Pubitemid 43361938)
17. Nikolova Z, Djonov V, Zuercher G, Andres AC, Ziemiecki A. Cell-type specifi c and estrogen dependent expression of the receptor tyrosine kinase EphB4 and its ligand ephrin-B2 during mammary gland morphogenesis. J Cell Sci. 1998;111(Pt 18):2741-51. (Pubitemid 28479198)
18. Munarini N, Jager R, Abderhalden S, Zuercher G, Rohrbach V, Loercher S, et al. Altered mammary epithelial development, pattern formation and involution in transgenic mice expressing the EphB4 receptor tyrosine kinase. J Cell Sci. 2002;115 (Pt 1):25-37. (Pubitemid 34105526)
19. LaMarca HL, Rosen JM. Estrogen regulation of mammary gland development and breast cancer: amphiregulin takes center stage. Breast Cancer Res. 2007;9:304.
20. Ciarloni L, Mallepell S, Brisken C. Amphiregulin is an essential mediator of estrogen receptor alpha function in mammary gland development. Proc Natl Acad Sci USA. 2007;104:5455-60. (Pubitemid 47175701)
21. Lee S, Medina D, Tsimelzon A, Mohsin SK, Mao S, Wu Y, et al. Alterations of gene expression in the development of early hyperplastic precursors of breast cancer. Am J Pathol. 2007;171:252-62. (Pubitemid 47339242)
22. Johnston SR. Clinical efforts to combine endocrine agents with targeted therapies against epidermal growth factor receptor/human epidermal growth factor receptor 2 and mammalian target of rapamycin in breast cancer. Clin Cancer Res. 2006;12(3 Pt 2):1061s-8s. (Pubitemid 43259844)
23. Shyamala G, Yang X, Silberstein G, Barcellos-Hoff MH, Dale E. Transgenic mice carrying an imbalance in the native ratio of A to B forms of progesterone receptor exhibit developmental abnormalities in mammary glands. Proc Natl Acad Sci USA. 1998;95:696-701. (Pubitemid 28083806)
24. Hovey RC, Trott JF, Ginsburg E, Goldhar A, Sasaki MM, Fountain SJ, et al. Transcriptional and spatiotemporal regulation of prolactin receptor mRNA and cooperativity with progesterone receptor function during ductal branch growth in the mammary gland. Dev Dyn. 2001;222: 192-205. (Pubitemid 32938481)
25. Schneider W, Ramachandran C, Satyaswaroop PG, Shyamala G. Murine progesterone receptor exists predominantly as the 83-kilodalton'A'form. J Steroid Biochem Mol Biol. 1991;38:285-91.
26. Conneely OM, Mulac-Jericevic B, Lydon JP, De Mayo FJ. Reproductive functions of the progesterone receptor iso-forms: lessons from knock-out mice. Mol Cell Endocrinol. 2001;179:97-103. (Pubitemid 32564956)
27. Brisken C, Park S, Vass T, Lydon JP, O'Malley BW, Weinberg RA. A paracrine role for the epithelial progesterone receptor in mammary gland development. Proc Natl Acad Sci USA. 1998 28;95:5076-81. (Pubitemid 28208553)
28. Humphreys RC, Lydon JP, O'Malley BW, Rosen JM. Use of PRKO mice to study the role of progesterone in mammary gland development. J Mammary Gland Biol Neoplasia. 1997;2:343-54. (Pubitemid 127718719)
29. Lewis AA, Gomez ET, Turner CW. Mammary gland development with mammogen I in the castrated and the hypo-physectomized rat. Endocrinology. 1942;30:37-47
30. Reece RP, Turner CW, Hill RT. Mammary gland development in the hypophysectomized albino rat. Proc Soc Exp Biol Med. 1936;34:204-217.
31. Ihle JN. STATs: signal transducers and activators of transcription. Cell. 1996;84:331-4. (Pubitemid 26058558)
32. Gallego MI, Binart N, Robinson GW, Okagaki R, Cosch-igano KT, Perry J, et al. Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects. Dev Biol. 2001;229: 163-75. (Pubitemid 32061721)
33. Zhou Y, He L, Kopchick JJ. An exon encoding the mouse growth hormone binding protein (mGHBP) carboxy terminus is located between exon 7 and 8 of the mouse growth hormone receptor gene. Receptor. 1994;4:223-7.
34. Zhou Y, Xu BC, Maheshwari HG, He L, Reed M, Lozykowski M, et al. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc Natl Acad Sci USA. 1997;94:13215-20. (Pubitemid 27518502)
35. Horseman ND, Zhao W, Montecino-Rodriguez E, Tanaka M, Nakashima K, Engle SJ, et al. Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene. EMBO J. 1997;16:6926-35. (Pubitemid 27520793)
36. Brisken C, Kaur S, Chavarria TE, Binart N, Sutherland RL, Weinberg RA, et al. Prolactin controls mammary gland development via direct and indirect mechanisms. Dev Biol. 1999;210:96-106. (Pubitemid 29275090)
37. Ormandy CJ, Binart N, Kelly PA. Mammary gland development in prolactin receptor knockout mice. J Mammary Gland Biol Neoplasia. 1997;2:355-64.
38. Santos SJ, Haslam SZ, Conrad SE. Signal transducer and activator of transcription 5a mediates mammary ductal branching and proliferation in the nulliparous mouse. Endocrinology. 2010;151:2876-85.
39. Sebastian J, Richards RG, Walker MP, Wiesen JF, Werb Z, Derynck R, et al. Activation and function of the epidermal growth factor receptor and erbB-2 during mammary gland morphogenesis. Cell Growth Differ. 1998;9:777-85. (Pubitemid 28425874)
40. Coleman S, Silberstein GB, Daniel C W. Ductal morphogenesis in the mouse mammary gland: evidence supporting a role for epidermal growth factor. Dev Biol. 1988;127:304-15.
41. Kenney NJ, Smith GH, Rosenberg K, Cutler ML, Dickson RB. Induction of ductal morphogenesis and lobular hyper-plasia by amphiregulin in the mouse mammary gland. Cell Growth Differ. 1996;7(1):1769-81. (Pubitemid 26415174)
42. Luetteke NC, Qiu TH, Fenton SE, Troyer KL, Riedel RF, Chang A, et al. Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. Development. 1999;126:2739-50. (Pubitemid 29338634)
43. Sternlicht MD, Sunnarborg SW, Kouros-Mehr H, Yu Y, Lee DC, Werb Z. Mammary ductal morphogenesis requires para-crine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin. Development. 2005;132: 3923-33. (Pubitemid 41410256)
44. Jackson-Fisher AJ, Bellinger G, Ramabhadran R, Morris JK, Lee KF, Stern DF. ErbB2 is required for ductal morphogenesis of the mammary gland. Proc Natl Acad Sci USA. 2004;101:17138-43. (Pubitemid 39627787)
45. Muraoka-Cook RS, Feng SM, Strunk KE, Earp HS 3rd. ErbB4/HER4: role in mammary gland development, differentiation and growth inhibition. J Mammary Gland Biol Neoplasia. 2008;13:235-46.
46. Jones FE, Jerry DJ, Guarino BC, Andrews GC, Stern DF. Heregulin induces in vivo proliferation and differentiation of mammary epithelium into secretory lobuloalveoli. Cell Growth Differ. 1996;7:1031-8. (Pubitemid 26360714)
47. Qu S, Rinehart C, Wu HH, Wang SE, Carter B, Xin H, et al. Gene targeting of ErbB3 using a Cre-mediated unidirectional DNA inversion strategy. Genesis. 2006;44:477-86. (Pubitemid 44684994)
48. Jackson-Fisher AJ, Bellinger G, Breindel JL, Tavassoli FA, Booth CJ, Duong JK, et al. ErbB3 is required for ductal morphogenesis in the mouse mammary gland. Breast Cancer Res. 2008;10:R96.
49. Schroeder JA, Lee DC. Dynamic expression and activation of ERBB receptors in the developing mouse mammary gland. Cell Growth Differ. 1998;9:451-64. (Pubitemid 28345870)
50. Tidcombe H, Jackson-Fisher A, Mathers K, Stern DF, Gassmann M, Golding JP. Neural and mammary gland defects in ErbB4 knockout mice genetically rescued from embryonic lethality. Proc Natl Acad Sci USA. 2003;100:8281-6. (Pubitemid 36842536)
51. Richert MM, Wood TL. The insulin-like growth factors (IGF) and IGF type I receptor during postnatal growth of the murine mammary gland: sites of messenger ribonucleic acid expression and potential functions. Endocrinology. 1999;140:454-61. (Pubitemid 29011191)
52. Wood TL, Richert MM, Stull MA, Allar MA. The insulinlike growth factors (IGFs) and IGF binding proteins in postnatal development of murine mammary glands. J Mammary Gland Biol Neoplasia. 2000;5:31-42.
53. Liu JL, LeRoith D. Insulin-like growth factor I is essential for postnatal growth in response to growth hormone. Endocrinology. 1999;140:5178-84.
54. Ruan W, Kleinberg DL. Insulin-like growth factor I is essential for terminal end bud formation and ductal morphogenesis during mammary development. Endocrinology. 1999; 140:5075-81.
55. Richards RG, Klotz DM, Walker MP, Diaugustine RP. Mammary gland branching morphogenesis is diminished in mice with a defi ciency of insulin-like growth factor-I (IGF-I), but not in mice with a liver-specifi c deletion of IGF-I. Endocrinology. 2004;145:3106-10. (Pubitemid 38829978)
56. Hadsell DL, Bonnette SG. IGF and insulin action in the mammary gland: lessons from transgenic and knockout models. J Mammary Gland Biol Neoplasia. 2000;5:19-30.
57. de Ostrovich KK, Lambertz I, Colby JK, Tian J, Rundhaug JE, Johnston D, et al. Paracrine overexpression of insulin-like growth factor-1 enhances mammary tumorigenesis in vivo. Am J Pathol. 2008;173:824-34.
58. Loladze AV, Stull MA, Rowzee AM, Demarco J, Lantry JH 3rd, Rosen CJ, et al. Epithelial-specifi c and stage-specifi c functions of insulin-like growth factor-I during postnatal mammary development. Endocrinology. 2006;147:5412-23. (Pubitemid 44790596)
59. Rowzee AM, Lazzarino DA, Rota L, Sun Z, Wood TL. IGF ligand and receptor regulation of mammary development. J Mammary Gland Biol Neoplasia. 2008;13:361-70.
60. Lee AV, Weng CN, Jackson JG, Yee D. Activation of estrogen receptor-mediated gene transcription by IGF-I in human breast cancer cells. J Endocrinol. 1997;152:39-47. (Pubitemid 27026386)
61. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, et al. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science. 1995;270:1491-4.
62. Lee AV, Yee D. Insulin-like growth factors and breast cancer. Biomed Pharmacother. 1995;49:415-21.
63. Ignar-Trowbridge DM, Pimentel M, Parker MG, McLach-lan JA, Korach KS. Peptide growth factor cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol. Endocrinology. 1996;137:1735-44. (Pubitemid 26133949)
64. Frasca F, Pandini G, Scalia P, Sciacca L, Mineo R, Costan-tino A, et al. Insulin receptor isoform A, a newly recognized, high-affi nity insulin-like growth factor II receptor in fetal and cancer cells. Mol Cellular Biol. 1999;19:3278-88. (Pubitemid 29193789)
65. Brisken C, Ayyannan A, Nguyen C, Heineman A, Reinhardt F, Tan J, et al. IGF-2 is a mediator of prolactin-induced morphogenesis in the breast. Dev Cell. 2002;3:877-87. (Pubitemid 35460787)
66. Hovey RC, Harris J, Hadsell DL, Lee AV, Ormandy CJ, Vonderhaar BK. Local insulin-like growth factor-II mediates prolactin-induced mammary gland development. Mol Endo-crinol. 2003;17:460-71. (Pubitemid 36315639)
67. Flint DJ, Tonner E, Beattie J, Allan GJ. Role of insulin-like growth factor binding proteins in mammary gland development. J Mammary Gland Biol Neoplasia. 2008;13:443-53.
68. Schwertfeger KL. Fibroblast growth factors in development and cancer: insights from the mammary and prostate glands. Curr Drug Targets. 2009;10:632-44.
69. Coleman-Krnacik S, Rosen JM. Differential temporal and spatial gene expression of fi broblast growth factor family members during mouse mammary gland development. Mol Endocrinol. 1994;8:218-29. (Pubitemid 24067109)
70. Imagawa W, Cunha GR, Young P, Nandi S. Keratinocyte growth factor and acidic fi broblast growth factor are mitogens for primary cultures of mammary epithelium. Biochem Bio-phys Res Commun. 1994;204:1165-9. (Pubitemid 24367174)
71. Ewald AJ, Brenot A, Duong M, Chan BS, Werb Z. Collective epithelial migration and cell rearrangements drive mammary branching morphogenesis. Dev Cell. 2008;14:570-81. (Pubitemid 351479940)
72. Guo L, Degenstein L, Fuchs E. Keratinocyte growth factor is required for hair development but not for wound healing. Genes Dev. 1996;10:165-75. (Pubitemid 26044604)
73. Luo Y, Lu W, Mohamedali KA, Jang JH, Jones RB, Gabriel JL, et al. The glycine box: a determinant of specifi city for fi broblast growth factor. Biochemistry. 1998;37:16506-15. (Pubitemid 28543909)
74. Wilson SE, Weng J, Chwang EL, Gollahon L, Leitch AM, Shay J W. Hepatocyte growth factor (HGF), keratinocyte growth factor (KGF), and their receptors in human breast cells and tissues: alternative receptors. Cell Mol Biol Res. 1994;40:337-50.
75. Pedchenko VK, Imagawa W. Pattern of expression of the KGF receptor and its ligands KGF and FGF-10 during postnatal mouse mammary gland development. Mol Reprod Dev. 2000;56:441-7. (Pubitemid 30456830)
76. Sekine K, Ohuchi H, Fujiwara M, Yamasaki M, Yoshizawa T, Sato T, et al. Fgf10 is essential for limb and lung formation. Nat Genet. 1999;21:138-41. (Pubitemid 29036301)
77. Watson CJ, Khaled WT. Mammary development in the embryo and adult: a journey of morphogenesis and commitment. Development. 2008;135:995-1003. (Pubitemid 351578128)
78. Silberstein GB, Daniel C W. Reversible inhibition of mammary gland growth by transforming growth factor-beta. Science. 1987;237:291-3. (Pubitemid 17095150)
79. Daniel CW, Silberstein GB, Van Horn K, Strickland P, Robinson S. TGF-beta 1-induced inhibition of mouse mammary ductal growth: developmental specifi city and characterization. Dev Biol. 1989;135:20-30. (Pubitemid 19225281)
80. Robinson SD, Silberstein GB, Roberts AB, Flanders KC, Daniel C W. Regulated expression and growth inhibitory effects of transforming growth factor-beta isoforms in mouse mammary gland development. Development. 1991;113:867-78. (Pubitemid 21900326)
81. Barcellos-Hoff MH, Ewan KB. Transforming growth factor-beta and breast cancer: Mammary gland development. Breast Cancer Res. 2000;2:92-9. (Pubitemid 32223571)
82. Ewan KB, Shyamala G, Ravani SA, Tang Y, Akhurst R, Wake-fi eld L, et al. Latent transforming growth factor-beta activation in mammary gland: regulation by ovarian hormones affects ductal and alveolar proliferation. Am J Pathol. 2002;160:2081-93. (Pubitemid 34663401)
83. Pierce DF Jr, Johnson MD, Matsui Y, Robinson SD, Gold LI, Purchio AF, et al. Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in trans-genic mice expressing active TGF-beta 1. Genes Dev. 1993;7:2308-17. (Pubitemid 24003235)
84. Snedeker SM, Brown CF, DiAugustine RP. Expression and functional properties of transforming growth factor alpha and epidermal growth factor during mouse mammary gland ductal morphogenesis. Proc Natl Acad Sci USA. 1991;88: 276-80. (Pubitemid 21914470)
85. Kenney NJ, Huang RP, Johnson GR, Wu JX, Okamura D, Matheny W, et al. Detection and location of amphiregulin and Cripto-1 expression in the developing postnatal mouse mammary gland. Mol Reprod Dev. 1995;41:277-86.
86. Ingman WV, Robertson SA. The essential roles of TGFB1 in reproduction. Cytokine Growth Factor Rev. 2009;20:233-9.
87. Silberstein GB, Flanders KC, Roberts AB, Daniel C W. Regulation of mammary morphogenesis: evidence for extracellular matrix-mediated inhibition of ductal budding by transforming growth factor-beta 1. Dev Biol. 1992;152:354-62.
88. Klinowska TC, Soriano JV, Edwards GM, Oliver JM, Valentijn AJ, Montesano R, et al. Laminin and beta1 integrins are crucial for normal mammary gland development in the mouse. Dev Biol. 1999;215:13-32. (Pubitemid 29519800)
89. Daniel CW, Strickland P, Friedmann Y. Expression and functional role of E-and P-cadherins in mouse mammary ductal morphogenesis and growth. Dev Biol. 1995;169:511-9.
90. Radice GL, Ferreira-Cornwell MC, Robinson SD, Rayburn H, Chodosh LA, Takeichi M, et al. Precocious mammary gland development in P-cadherin-defi cient mice. J Cell Biol. 1997;139:1025-32. (Pubitemid 27508572)
91. Srinivasan K, Strickland P, Valdes A, Shin GC, Hinck L. Netrin-1/neogenin interaction stabilizes multipotent progenitor cap cells during mammary gland morphogenesis. Dev Cell. 2003;4:371-82. (Pubitemid 36342362)
92. Morris JS, Stein T, Pringle MA, Davies CR, Weber-Hall S, Ferrier RK, et al. Involvement of axonal guidance proteins and their signaling partners in the developing mouse mammary gland. J Cellular Physiol. 2006;206:16-24. (Pubitemid 41740713)
93. Yant J, Buluwela L, Niranjan B, Gusterson B, Kamalati T. In vivo effects of hepatocyte growth factor/scatter factor on mouse mammary gland development. Exp Cell Res. 1998; 241:476-81. (Pubitemid 28366573)
94. Yi ES, Bedoya AA, Lee H, Kim S, Housley RM, Aukerman SL, et al. Keratinocyte growth factor causes cystic dilation of the mammary glands of mice. Interactions of keratinocyte growth factor, estrogen, and progesterone in vivo. Am J Pathol. 1994;145:1015-22. (Pubitemid 24345648)
95. Lu P, Ewald AJ, Martin GR, Werb Z. Genetic mosaic analysis reveals FGF receptor 2 function in terminal end buds during mammary gland branching morphogenesis. Dev Biol. 2008;321:77-87.
96. Kleinberg DL. Early mammary development: growth hormone and IGF-1. J Mammary Gland Biol Neoplasia. 1997; 2:49-57. (Pubitemid 127717412)
97. Ruan W, Newman CB, Kleinberg DL. Intact and amino-terminally shortened forms of insulin-like growth factor I induce mammary gland differentiation and development. Proc Natl Acad Sci USA. 1992;89:10872-6.
98. Bonnette SG, Hadsell DL. Targeted disruption of the IGF-I receptor gene decreases cellular proliferation in mammary terminal end buds. Endocrinology. 2001;142:4937-45. (Pubitemid 33022370)
99. Allar MA, Wood TL. Expression of the insulin-like growth factor binding proteins during postnatal development of the murine mammary gland. Endocrinology. 2004;145:2467-77. (Pubitemid 38535074)
100. Asselin-Labat ML, Sutherland KD, Barker H, Thomas R, Shackleton M, Forrest NC, et al. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat Cell Biol. 2007;9:201-9. (Pubitemid 46420863)
101. Kouros-Mehr H, Slorach EM, Sternlicht MD, Werb Z. GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell. 2006;127:1041-55. (Pubitemid 44792255)
102. Humphreys RC, Krajewska M, Krnacik S, Jaeger R, Weiher H, Krajewski S, et al. Apoptosis in the terminal endbud of the murine mammary gland: a mechanism of ductal morphogenesis. Development. 1996;122:4013-22. (Pubitemid 27033895)
103. Mailleux AA, Overholtzer M, Schmelzle T, Bouillet P, Strasser A, Brugge JS. BIM regulates apoptosis during mammary ductal morphogenesis, and its absence reveals alternative cell death mechanisms. Dev Cell. 2007;12:221-34. (Pubitemid 46172902)
104. Nelson CM, Vanduijn MM, Inman JL, Fletcher DA, Bissell MJ. Tissue geometry determines sites of mammary branching morphogenesis in organotypic cultures. Science. 2006; 314:298-300. (Pubitemid 44571974)
105. Joseph H, Gorska AE, Sohn P, Moses HL, Serra R. Overex-pression of a kinase-defi cient transforming growth factor-beta type II receptor in mouse mammary stroma results in increased epithelial branching. Mol Biology Cell. 1999;10: 1221-34. (Pubitemid 29193742)
106. Kamalati T, Niranjan B, Yant J, Buluwela L. HGF/SF in mammary epithelial growth and morphogenesis: in vitro and in vivo models. J Mammary Gland Biol Neoplasia. 1999;4: 69-77.
107. Niranjan B, Buluwela L, Yant J, Perusinghe N, Atherton A, Phippard D, et al. HGF/SF: a potent cytokine for mammary growth, morphogenesis and development. Development. 1995;121:2897-908.
108. Soriano JV, Pepper MS, Orci L, Montesano R. Roles of hepatocyte growth factor/scatter factor and transforming growth factor-beta1 in mammary gland ductal morphogenesis. J Mammary Gland Biol Neoplasia. 1998;3: 133-50. (Pubitemid 128513226)
109. Pollard J W. Tumour-stromal interactions. Transforming growth factor-beta isoforms and hepatocyte growth factor/ scatter factor in mammary gland ductal morphogenesis. Breast Cancer Res. 2001;3:230-7. (Pubitemid 32631702)
110. Soriano JV, Pepper MS, Nakamura T, Orci L, Montesano R. Hepatocyte growth factor stimulates extensive development of branching duct-like structures by cloned mammary gland epithelial cells. J Cell Sci. 1995;108 (Pt 2):413-30.
111. Berdichevsky F, Alford D, D'Souza B, Taylor-Papadimitriou J. Branching morphogenesis of human mammary epithelial cells in collagen gels. J Cell Sci. 1994;107 (Pt 12):3557-68.
112. Alford D, Baeckstrom D, Geyp M, Pitha P, Taylor-Papadimitriou J. Integrin-matrix interactions affect the form of the structures developing from human mammary epithelial cells in collagen or fi brin gels. J Cell Sci. 1998;111 (Pt 4):521-32. (Pubitemid 28098400)
113. Brisken C, Heineman A, Chavarria T, Elenbaas B, Tan J, Dey SK, et al. Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling. Genes Dev. 2000;14:650-4. (Pubitemid 30176819)
114. Creamer BA, Sakamoto K, Schmidt JW, Triplett AA, Moriggl R, Wagner KU. Stat5 promotes survival of mammary epithelial cells through transcriptional activation of a distinct promoter in Akt1. Mol Cell Biol. 2010;30:2957-70.
115. Lembo G, Rockman HA, Hunter JJ, Steinmetz H, Koch WJ, Ma L, et al. Elevated blood pressure and enhanced myocar-dial contractility in mice with severe IGF-1 defi ciency. J Clin Invest. 1996;98:2648-55. (Pubitemid 26415088)
116. Kenney NJ, Bowman A, Korach KS, Barrett JC, Salomon DS. Effect of exogenous epidermal-like growth factors on mammary gland development and differentiation in the estrogen receptor-alpha knockout (ERKO) mouse. Breast Cancer Res Treat. 2003;79:161-73. (Pubitemid 36656337)
117. Shioda T, Lechleider RJ, Dunwoodie SL, Li H, Yahata T, de Caestecker MP, et al. Transcriptional activating activity of Smad4: roles of SMAD hetero-oligomerization and enhancement by an associating transactivator. Proc Natl Acad Sci USA. 1998;95:9785-90.
118. Ewan KB, Oketch-Rabah HA, Ravani SA, Shyamala G, Moses HL, Barcellos-Hoff MH. Proliferation of estrogen receptor-alpha-positive mammary epithelial cells is restrained by transforming growth factor-beta1 in adult mice. Am J Pathol. 2005;167:409-17. (Pubitemid 43026097)
119. Andrechek ER, White D, Muller WJ. Targeted disruption of ErbB2/Neu in the mammary epithelium results in impaired ductal outgrowth. Oncogene. 2005;24:932-7. (Pubitemid 40216100)
120. Wiseman BS, Sternlicht MD, Lund LR, Alexander CM, Mott J, Bissell MJ, et al. Site-specifi c inductive and inhibitory activities of MMP-2 and MMP-3 orchestrate mammary gland branching morphogenesis. J Cell Biol. 2003;162:1123-33. (Pubitemid 37174194)
121. Deome KB, Faulkin LJ Jr, Bern HA, Blair PB. Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice. Cancer Res. 1959;19:515-20.
122. Smith GH. Experimental mammary epithelial morphogenesis in an in vivo model: evidence for distinct cellular progenitors of the ductal and lobular phenotype. Breast Cancer Res Treat. 1996;39:21-31. (Pubitemid 26136501)
123. Kordon EC, Smith GH. An entire functional mammary gland may comprise the progeny from a single cell. Development. 1998;125:1921-30. (Pubitemid 28274378)
124. Chepko G, Smith GH. Three division-competent, structurally-distinct cell populations contribute to murine mammary epithelial renewal. Tissue Cell. 1997;29:239-53. (Pubitemid 27197107)
125. Kordon EC, Smith GH, Callahan R, Gallahan D. A novel non-mouse mammary tumor virus activation of the Int-3 gene in a spontaneous mouse mammary tumor. J Virol. 1995;69:8066-9.
126. Wainscoat JS, Fey MF. Assessment of clonality in human tumors: a review. Cancer Res. 1990;50:1355-60. (Pubitemid 20090440)
127. Shackleton M, Vaillant F, Simpson KJ, Stingl J, Smyth GK, Asselin-Labat ML, et al. Generation of a functional mammary gland from a single stem cell. Nature. 2006;439:84-8. (Pubitemid 43053633)
128. Zeps N, Dawkins HJ, Papadimitriou JM, Redmond SL, Walters MI. Detection of a population of long-lived cells in mammary epithelium of the mouse. Cell Tissue Res. 1996; 286:525-36. (Pubitemid 26418061)
129. Stingl J, Eirew P, Ricketson I, Shackleton M, Vaillant F, Choi D, et al. Purifi cation and unique properties of mammary epithelial stem cells. Nature. 2006;439:993-7. (Pubitemid 43292419)
130. Williams JM, Daniel CW. Mammary ductal elongation: differentiation of myoepithelium and basal lamina during branching morphogenesis. Dev Biol. 1983;97:274-90. (Pubitemid 13029836)
131. Sapino A, Macri L, Gugliotta P, Pacchioni D, Liu YJ, Medina D, et al. Immunophenotypic properties and estrogen dependency of budding cell structures in the developing mouse mammary gland. Differentiation. 1993;55:13-18. (Pubitemid 24006218)
132. Kurpios NA, MacNeil L, Shepherd TG, Gludish DW, Giacomelli AO, Hassell JA. The Pea3 Ets transcription factor regulates differentiation of multipotent progenitor cells during mammary gland development. Dev Biol. 2009; 325:106-21.
133. Benz CC, O'Hagan RC, Richter B, Scott GK, Chang CH, Xiong X, et al. HER2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancer. Oncogene. 1997;15:1513-25. (Pubitemid 27464644)
134. Jiang P, Hu Q, Ito M, Meyer S, Waltz S, Khan S, et al. Key roles for MED1 LxxLL motifs in pubertal mammary gland development and luminal-cell differentiation. Proc Natl Acad Sci USA. 2010;107:6765-70.
135. Latres E, Malumbres M, Sotillo R, Martin J, Ortega S, Martin-Caballero J, et al. Limited overlapping roles of P15(INK4b) and P18(INK4c) cell cycle inhibitors in proliferation and tumorigenesis. EMBO J. 2000;19:3496-506. (Pubitemid 30428227)
136. Kouros-Mehr H, Bechis SK, Slorach EM, Littlepage LE, Egeblad M, Ewald AJ, et al. GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model. Cancer cell. 2008;13:141-52. (Pubitemid 351163164)
137. Eeckhoute J, Keeton EK, Lupien M, Krum SA, Carroll JS, Brown M. Positive cross-regulatory loop ties GATA-3 to estrogen receptor alpha expression in breast cancer. Cancer Res. 2007;67:6477-83. (Pubitemid 47037533)
138. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med. 2002;347:1999-2009. (Pubitemid 35461656)
139. Pei XH, Bai F, Smith MD, Usary J, Fan C, Pai SY, et al. CDK inhibitor p18(INK4c) is a downstream target of GATA3 and restrains mammary luminal progenitor cell proliferation and tumorigenesis. Cancer cell. 2009;15:389-401.
140. Althuis MD, Fergenbaum JH, Garcia-Closas M, Brinton LA, Madigan MP, Sherman ME. Etiology of hormone receptor-defi ned breast cancer: a systematic review of the literature. Cancer Epidemiol Biomarkers Prev. 2004;13:1558-68. (Pubitemid 39331875)
141. Sparmann A, van Lohuizen M. Polycomb silencers control cell fate, development and cancer. Nat Rev Cancer. 2006; 6:846-56. (Pubitemid 44629896)
142. van der Lugt NM, Domen J, Linders K, van Roon M, Robanus-Maandag E, te Riele H, et al. Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene. Genes Dev. 1994;8:757-69.
143. Park IK, Qian D, Kiel M, Becker MW, Pihalja M, Weissman IL, et al. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature. 2003;423:302-5. (Pubitemid 40852701)
144. Molofsky AV, Pardal R, Iwashita T, Park IK, Clarke MF, Morrison SJ. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature. 2003;425:962-7. (Pubitemid 37376927)
145. Pietersen AM, Evers B, Prasad AA, Tanger E, Cornelissen-Steijger P, Jonkers J, van Lohuizen M. Bmi1 regulates stem cells and proliferation and differentiation of committed cells in mammary epithelium. Curr Biol. 2008;18:1094-9.
146. Dontu G, El-Ashry D, Wicha MS. Breast cancer, stem/progenitor cells and the estrogen receptor. Trends Endocrinol Metab. 2004;15:193-7. (Pubitemid 38833988)
147. Asselin-Labat ML, Shackleton M, Stingl J, Vaillant F, Forrest NC, Eaves CJ, et al. Steroid hormone receptor status of mouse mammary stem cells. J Natl Cancer Inst. 2006;98: 1011-4. (Pubitemid 44288166)
148. Sleeman KE, Kendrick H, Robertson D, Isacke CM, Ashworth A, Smalley MJ. Dissociation of estrogen receptor expression and in vivo stem cell activity in
149. Asselin-Labat ML, Vaillant F, Sheridan JM, Pal B, Wu D, Simpson ER, et al. Control of mammary stem cell function by steroid hormone signalling. Nature. 2010;465: 798-803.
150. Joshi PA, Jackson HW, Beristain AG, Di Grappa MA, Mote PA, Clarke CL, et al. Progesterone induces adult mammary stem cell expansion. Nature. 2010;465:803-7.
151. Kenney NJ, Smith GH, Lawrence E, Barrett JC, Salomon DS. Identifi cation of stem cell units in the terminal end bud and duct of the mouse mammary gland. J Biomed Biotechnol. 2001;1:133-43. (Pubitemid 46842820)
152. Taddei I, Deugnier MA, Faraldo MM, Petit V, Bouvard D, Medina D, et al. Beta1 integrin deletion from the basal compartment of the mammary epithelium affects stem cells. Nat Cell Biol. 2008;10:716-22. (Pubitemid 351772937)
153. Deugnier MA, Faraldo MM, Teuliere J, Thiery JP, Medina D, Glukhova MA. Isolation of mouse mammary epithelial progenitor cells with basal characteristics from the Comma-Dbeta cell line. Dev Biol. 2006;293:414-25.
154. Danielson KG, Oborn CJ, Durban EM, Butel JS, Medina D. Epithelial mouse mammary cell line exhibiting normal morphogenesis in vivo and functional differentiation in vitro. Proc Natl Acad Sci USA. 1984;81:3756-60. (Pubitemid 14087797)
155. Booth BW, Boulanger CA, Anderson LH, Jimenez-Rojo L, Brisken C, Smith GH. Amphiregulin mediates self-renewal in an immortal mammary epithelial cell line with stem cell characteristics. Exp Cell Res. 2010;316:422-32.
156. McBryan J, Howlin J, Kenny PA, Shioda T, Martin F. ERalpha-CITED1 co-regulated genes expressed during pubertal mammary gland development: implications for breast cancer prognosis. Oncogene. 2007;26:6406-19. (Pubitemid 47494221)
157. Gouon-Evans V, Rothenberg ME, Pollard JW. Postnatal mammary gland development requires macrophages and eosinophils. Development. 2000;127:2269-82. (Pubitemid 30386567)
158. Li W, Ferguson BJ, Khaled WT, Tevendale M, Stingl J, Poli V, et al. PML depletion disrupts normal mammary gland development and skews the composition of the mammary luminal cell progenitor pool. Proc Natl Acad Sci USA. 2009;106:4725-30.
159. Kariagina A, Aupperlee MD, Haslam SZ. Progesterone receptor isoform functions in normal breast development and breast cancer. Crit Rev Eukaryot Gene Expr. 2008;18:11-33. (Pubitemid 350259932)
160. LeRoith D. Clinical relevance of systemic and local IGF-I: lessons from animal models. Pediatr Endocrinol Rev. 2008;5 Suppl 2:739-43.
161. Falls DL. Neuregulins: functions, forms, and signaling strategies. Exp Cell Res. 2003;284:14-30. (Pubitemid 36335807)
162. Stern DF. ERBB3/HER3 and ERBB2/HER2 duet in mammary development and breast cancer. J Mammary Gland Biol Neoplasia. 2008;13:215-23.
163. Schwertfeger KL, Rosen JM, Cohen DA. Mammary gland macrophages: pleiotropic functions in mammary development. J Mammary Gland Biol Neoplasia. 2006;11:229-38. (Pubitemid 44869918)
164. Whyte J, Bergin O, Bianchi A, McNally S, Martin F. Key signalling nodes in mammary gland development and cancer. Mitogen-activated protein kinase signalling in experimental models of breast cancer progression and in mammary gland development. Breast Cancer Res. 2009;11:209.